Amitriptyline is a TrkA and TrkB Receptor Agonist that Promotes TrkA/TrkB Heterodimerization and Has Potent Neurotrophic Activity
- 26 June 2009
- journal article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 16 (6), 644-656
- https://doi.org/10.1016/j.chembiol.2009.05.010
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NS045627)
This publication has 43 references indexed in Scilit:
- Cholinergic system during the progression of Alzheimer’s disease: therapeutic implicationsExpert Review of Neurotherapeutics, 2008
- Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effectProceedings of the National Academy of Sciences of the United States of America, 2008
- Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell deathProceedings of the National Academy of Sciences of the United States of America, 2007
- Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult ratsMolecular Psychiatry, 2002
- Nerve Growth Factor (NGF) Loop 4 Dimeric Mimetics Activate ERK and AKT and Promote NGF-like Neurotrophic EffectsPublished by Elsevier BV ,2000
- TrkA Amino Acids Controlling Specificity for Nerve Growth FactorPublished by Elsevier BV ,2000
- Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 bind to a single leucine-rich motif of TrkBBiochemistry, 1995
- Small Peptide Mimics of Nerve Growth Factor Bind TrkA Receptors and Affect Biological ResponsesPublished by Elsevier BV ,1995
- Neurotrophin signal transduction by the Trk receptorJournal of Neurobiology, 1994
- Basic FGF, NGF, and IGFs Protect Hippocampal and Cortical Neurons against Iron-Induced DegenerationJournal of Cerebral Blood Flow & Metabolism, 1993